Accordingly, we examined potential confounding by demographic factors (i.e. age and sex), IFNL4 genotype, which was not available in previous studies, and a comprehensive suite of systematically measured clinical markers of liver disease. The gene discussed is IFNL4; the disease is liver disorder.